Hosted on MSN1mon
Teva to divest API unit to focus on core business strengthsTeva (NYSE:TEVA) plans to divest its active-pharmaceutical ingredient (API) business as part of its Pivot to Growth strategy to focus on its core business strengths. "The intent to divest TAPI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback